-
ACLA Letter to HHS on Data Reporting
-
ACLA Letter to CDC on Antibody Guidance
-
ACLA Serologic Testing White Paper
-
ACLA Letter to HHS on PHSSEF Direct COVID19 Test Funding
-
ACLA Serologic Testing Executive Summary
-
ACLA Letter To CDC on Prioritization
-
Letter to HHS on COVID-19 Provider Fund
-
ACLA Letter to Congressional Leadership on COVID-19
-
LAB Act Co-Sponsors Letter to CMS
-
ACLA Files A Motion for Summary Judgment Against HHS In ACLA v. Azar
Washington, D.C. — Following a favorable decision on a jurisdictional question issued by the U.S. Court of Appeals for the D.C. Circuit, the American Clinical Laboratory Association ... Read More
